sifalimumab human monoclonal antibody designed treatment sle dermatomyositis targets interferon sifalimumab developed medimmune development terminated favor moving competing internal product anifrolumab phase iii immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikisifalimumab